The cell surface receptor for interleukin 2 plays a central role in the biology of this T-cell growth factor. A combination of affinity chromatography,-high.-performance liquid chromatography, and NH2-ternnmal protein sequencing was used to purify and chemically characterize the interleukin 2 receptor both frokn phytohemnagglutinin-activated T cells and from the human T-cell lymphoma cell line HuT-102. The receptor isolated from HuT-102 cells was purifie4 16,000-fold to homogeneity as evidenced by (i) a final specitic activity close to the theoretical specific activity, of 18,182 fniol of receptor per Pug of protein, (it) a single band on polyacrylamide gel electrophoresis with an.Mr of 55,000, and (Wi) a unique, unambiguous NH2-terminal protein sequence. The receptor purified from
phytohemagglutinih-activated T lymphocytes had an Mr of 60,000 but it had the same NH2-terminal protein sequence.
The generation of a normal immune response requires a complex series of interactions between cells of several different phenotypes. The molecular nature of these interactions is still not completely understood, but one mechanism by which cell-to-cell communication does occur in this system is by the elaboration of lymphokines by one cell type that bind to a second cell type.
Perhaps the best understood. lymphokine system is that which involves interleukin 2 (IL-2). The participation of T cells is crucial to the success of many immune responses. T cells require IL-2 to proliferate (1, 2) , and coincident with the ability of T cells to respond to IL-2 is the appearance on these cells of a receptor glycoprotein specific for this lymphokine (3, 4) . Three monoclonal antibodies have been described that are specific for the human IL-2 receptor. The first, anti-Tac (5) (6) (7) (8) , was shown to react only with activated T cells and, more recently, to bind to the same molecule that binds to IL-2 (9) . The second, B1-49-9 (10) , competitively inhibits the binding of anti-Tac to cells (unpublished work) and immunoprecipitates the same molecule from detergent lysates of radiolabeled cells (10) ; thus, 1i-49-9 recognizes an antigenic epitope on the receptor molecule that is identical to or near to the epitope detected with anti-Tac. A third monoclonal antibody, 2A3, was recently isolated by our laboratory. This monoclonal antibody reacted with the same antigen that is recognized by anti-Tac and B1-49-9 as evidenced by the observations ttat 2A3 and B149-9 completely itross-compete for binding to activated human T cells and that the antigen precipitated by 2A3 is precleared from 125I-labeled activated T-cell lysates by B1-49-1, and that the reverse is also true (unpublished work).
Knowledge of the biochemistry of the IL-2 receptor is important to completely understand the biology of IL-2. Fur-thermore, in light of the recent finding that certain onc genes are homologous to growth factor receptors (13) , it is of interest to compare the IL-2 receptor isolated from both normal and malignant cells.
The IL-2 receptor on activated T cells has been characterized by radioimmunoprecipitation as a glycoprotlin of Mr 55,000-60,000 (9, 10). By using the same radi6immunoprecipitation technique with the same antibodies, the receptor present on the T-cell lymphoma HuT-102 is consistently found tq be of lower molecular weight, around Mr 50,000-55,000 (7, 10, 14) . We report here the purification and chemical characterization of the IL-2 receptor from activated T cells and from HuT-102 cells.
MATERIALS AND METHODS Antibody. The 2A3 hybridoma cell line resulted from the fusion of NS-1 myeloma cells with spleen cells from mice that had been immunized with phytohemagglutinin (PHA)activated human peripheral blood lymphocytes (PBL). The isolation and complete characterization, of this antibody is the subject of a separate report (unpublished work). Immunoglobulin was purified from 2A3 ascites fluid by ammoniurti sulfate precipitation, DE52 ion-exchange chromatography (Whatman), and gel filtration on ACA-34 (LKB).
A convenient control antibody of the same isotype (IgG1, K) is secreted by the mouse myeloma cell line MOPC-21. This antibody was obtained from Litton Biohetics.
Iodination of Antibody. 2A3 was radiolabeled with 1251 (1251-2A3) by a chloramine-T method as described (15) . The 1251-2A3 routinely had a specific activity of 2-5 x 10's cpm/mmol ( (18) ; hence, work with the HuT-102 cell line was performed in a P-3 isolation facility Abbreviations: IL-2, interleukin 2; BSA, bovihe serum albumin; Gdn HCI guanidine hydrochloride; PBL, periheral blood lymphocytes; PhA, phytohemagglutinin; PhMeSO2F, phenylmethylsulfonyl fluoride; CF3COOHj trifluoroacetic acid.
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Human peripheral blood mononuclear cells were prepared by Ficoll-Hypaque centrifugation as described (19) . Adherent cells were removed by plastic adherence as described (19) . Mitogen activation was done with PHA-P (Difco) in RPMI 1640 medium containing 10% fetal calf serum according to standard conditions (19) . Cells were harvested by centrifugation 72 hr after mitogen stimulation, a time period previously established as optimal for IL-2 receptor expression.
Membranes were prepared from HuT-102 and PHA-PBL (72 hr after PHA activation) in the same way. Briefly, cells were harvested by centrifugation and washed three times in P,/NaCl. The cell pellet (1 vol) was then suspended in 3 vol of P1/NaCl containing 1% (wt/vol) Triton X-100 and 2 mM phenylmethylsulfonyl fluoride (PhMeSO2F) and kept on ice with periodic mixing in a vortex for 30 min. The extract was then centrifuged at 20,000 x g for 20 min to remove nuclei and insoluble debris. Cell extracts were stored at -70'C until used.
Soluble Receptor Assays. The first assay is to be described in detail elsewhere. Briefly, 50-1.d aliquots of receptor-containing solutions in P1/NaCl/1% Triton were tested for their capacity to bind I251-2A3 antibody by incubation with 50 1 of antibody solution (0.3 nM) for 1 hr at 20'C. Unbound 12I-2A3 was measured by addition of 50 ul of a suspension of fixed (1% glutaraldehyde) PHA-PBL (2 x 108 cells per ml) and a further 1-hr incubation. At the end of the second incubation cell-bound antibody could be detected by pelleting the cells through a phthalate oil mixture, as described (25) . The inhibitory capacity of receptor-containing solutions was measured relative to Pi/NaCl/1% Triton alone as the positive control (0% inhibition) and P1/NaCl/1% Triton containing 0.01 ,uM unlabeled 2A3 as the negative control (100% inhibition). The assay was calibrated with samples of known receptor content. Briefly, the dilution of receptor solution producing 50% inhibition (D50) of labeled 2A3 binding to fixed PHA-PBL was directly related to the concentration of receptors present in the initial cell lysate, as determined by the direct binding of 1251-2A3 to the intact cells prior to solution in detergent. Hence, the amount of receptor in solution (pmol or ng) could be determined from the D50 and this standard curve.
The nitrocellulose "dot" assay for the presence of receptor protein was performed as follows. Serial dilutions of receptor-containing solutions were made in Pi/NaCl containing 1% Triton X-100. Aliquots (5 ,ul) of these dilutions were then applied to a piece of dry nitrocellulose (Schleicher & Schuell); The nitrocellulose was then "blocked" by overnight incubation in 10 ml of 0.05 M Tris HCI, pH 7.5/0.15 M NaCI/3% bovine serum albumin (Tris/3% BSA). After blocking, the nitrocellulose was incubated for 1 hr at room temperature in 10 ml of Tris/3% BSA containing 0.05 ,ug of radioiodinated 2A3 per ml and 0.6 ,ug of unlabeled MOPC-21 per ml. The dot blot was then washed three times in Tris/ NaCl and two times in RIPA buffer. Each wash lasted 30 min at room temperature. After the final wash, the nitrocellulose sheet was blotted dry on a paper towel, covered in Saran-Wrap, and exposed at -70°C to Kodak X-Omat AR film. The amount of receptor in a solution was estimated by comparing, in each assay, the end point of the unknown solution with the end point of the titration of a detergent solution of PHA-PBL that had been previously assayed in the soluble receptor assay outlined above.
IL-2 Receptor Purification. MOPC-21 and 2A3 columns were poured in 3-ml syringes that were adapted at the open end with a cork and tubing such that the columns could be run in either direction. The Pi/NaCI/1% Triton X-100 extract of 2 x 109 HuT-102 cells (25 ml) was first applied to a 1.5-ml column of MOPC-21 coupled to Affi-Gel at a flow rate of 0.1 ml/min in order to remove proteins that nonspecifically bound to mouse IgG. This absorption was repeated before applying the flow-through from the MOPC-21 column to a 1.5-ml column of 2A3 coupled to Affi-Gel 10. The post-MOPC-21 material was pasted through the 2A3 column twice before the flow was reversed through the column for elution of the bound receptor. After loading, the 2A3 column was washed with 10 column vol of Pi/NaCl/1% Triton X-100, with 10 column vol of RIPA buffer, and finally with Pi/NaCl/1% Triton X-100. Six molar guanidine hydrochloride (Gdn-HCl) in 0.5% Triton X-100 was used to elute bound receptor from the column and 1.2ml fractions were collected. Each fraction was dialyzed against 3 M Gdn HCl in 0.5% Triton X-100 for 4 hr, followed by dialysis against 1.5 M Gdn HCl in 0.5% Triton X-100. Final dialysis was performed against Pi/NaCl containing 0.5% Triton X-100. Aliquots at each stage of the purification were saved for analysis of biological activity by the soluble receptor assay, analysis of proteins by the fluorescamine assay with BSA as standard (20) , and analysis by polyacrylamide gel electrophoresis (21, 22) with protein detection using the silver stain method previously described (23) .
Purification of the PHA-PBL receptor for IL-2 was performed in an identical fashion. A Pi/NaCl/1% Triton X-100 extract of 15 x 109 cells (134 ml) was processed through the same series of columns and analyses. HPLC. Chromatography was performed with a Waters Associates liquid chromatograph equipped with two model M-45 pumps, a model 720 system controller, and a model 441 absorbance detector monitoring at 214 nm. Solvents were purchased from Burdick and Jackson (Muskegon, MI).
Receptor-containing fractions from the affinity purification step were injected onto a 3.9 mm x 15 cm Vydac C-4 reversed-phase column (Separations Group, Hesperia, CA) that had been equilibrated in 0.1% (vol/vol) trifluoroacetic acid (CF3COOH) in H20. A 1%/min gradient of solvent B [acetonitrile containing 0.1% (vol/vol) CF3COOH] was established to elute proteins off the column. One-minute fractions were collected (1 ml) and 50-pl aliquots were removed from each one for analysis by polyacrylamide gel electrophoresis as described (24) . Aliquots for biological assay were dried in vacuo in the presence of 50 ,ug of BSA. The dried residue was resuspended in P1/NaCI/2% Triton X-100 for analysis in the soluble receptor assay.
Protein . Uncomplexed 1251-2A3 was detected by the addition of 2 x 106 glutaraldehyde-fixed PHA-PBL, and specific inhibition of binding of the antibody to the cells was calculated. (B) Nitrocellulose dot assay. Five microliters of dilutions of detergent lysates of PHA-PBL was applied to dry nitrocellulose prior to the passage of the lysate through a 2A3 affinity column (Start), after passage (Post 2A3), and after elution of bound receptor with 6 M Gdn HCI (Gdn'HCI eluate). The numbers below the dots refer to the amount of receptor that was detected in the original solution by the soluble receptor assay outlined in A. tion, we exploited the observation that the IL-2 receptor on PHA-activated T cells was stable to glutaraldehyde fixation. After such treatment, the receptor could not be extracted from cells with nonionic detergents such as Triton X-100, and the presence of detergent only marginally affected the binding of radiolabeled 2A3 antibody to the fixed cells (unpublished work). Preincubation of detergent solutions containing the IL-2 receptor with low concentrations of iodinated 2A3 inhibited the subsequent binding of 1251-2A3 to the fixed cells. As shown in Fig. 1A , detergent-dissolved membrane from PHA-activated T cells inhibited the binding of radiolabeled 2A3 to glutaraldehyde-fixed cells, whereas the same material after passage through a 2A3 affinity column no longer had the capacity to inhibit this reaction. This assay allowed us to determine mol of receptor per unit of protein in our preparations and hence to monitor our purification scheme by specific activity.
A less quantitative but more convenient and sensitive assay for the presence of receptor in solution was the nitrocellulose dot assay illustrated in Fig. 1B . Receptor containing fractions bound to nitrocellulose could be readily detected by radiolabeled 2A3 antibody. As little as 0.03 ng of receptor protein bound to nitrocellulose could be detected by overnight development of the x-ray film.
Receptor Purification from HuT-102 Cells. Table 1 summarizes the purification scheme. Aliquots representing the various stages of this purification protocol were analyzed by polyacrylamide gel electrophoresis followed by silver stain. It is clear from Fig. 2A 2A3 affinity column was not homogeneous. Furthermore, the soluble receptor assay revealed that the receptor activity had eluted in a broad peak off the column (five fractions). Chromatography on a Vydac C-4 reversed-phase column in 0.1% CF3COOH in acetonitrile achieved purification of the receptor to a single band as detected by silver staining on a polyacrylamide gel (Fig. 2B) ; 50-55% acetonitrile eluted the receptor off the column. The Mr of the HuT-102 receptor was calculated to be 55,000. The receptor had been purified from 1.26 fmol/,g of protein in the starting material to 21,200 fmol of receptor per ,g of protein after the HPLC step. Theoretical purity of the HuT-102 receptor would be 18,182 fmol/,ug of protein.
Receptor Purification from PHA-Activated Human T Cells. IL-2 receptor expression on human T cells reaches a maximum at 72 hr after stimulation with PHA (19) . Even at its peak, however, the number of receptors on activated T cells remains lower by a factor of 5-10 than the number of receptors found constitutively on HuT-102 cells. This is reflected in the 6-fold difference in specific activity as measured by the soluble receptor assay of the starting material for HuT- 14 21,000 16,667 Protein concentration in fractions 1-3 was determined by the fluorescamine assay (20) with BSA as standard. Protein in fractions 4 and 5 was estimated from silver-stained gels and from protein sequencer data. The same sequence of steps outlined for the purification of the HuT-102 receptor was followed for the purification of the PHA-PBL receptor. Fig. 3 illustrates that the PHA-PBL receptor eluted at the same position on HPLC as the HuT-102 receptor. It is, however, Mr 60,000 as opposed to Mr 55,000 for the HuT-102 receptor. The final specific activity of the PHA-PBL receptor was 5000 fmol/Ag, reflecting to some extent the lower specific activity of the starting material. Theoretical purity of the PHA-PBL receptor would be 16, 667 fmol/Ag of protein.
Protein Sequencing of the IL-2 Receptor. An unambiguous sequence was obtained for the receptor isolated from HuT-102 cells. It is depicted in Fig. 4 with the sequence obtained from the receptor isolated from PHA-PBL. The two sequences were identical. Sulfhydryl groups were not modified before sequencing; thus, cysteine was not detectable. However, no significantly high signals for other residues were detected at position 3 and the residues surrounding this position were not consistent with the blank being an Nor 0linked glycosylation site. Hence, position 3 was designated cysteine.
The NH2-terminal amino acid sequence for the IL-2 receptor was compared with known protein sequences in the National Biomedical Research Foundation protein data base by using the SEARCH program (January 1984 edition). The IL-2 receptor sequence was unique.
DISCUSSION
The monoclonal antibody 2A3 binds to activated T cells, but only to a small extent to resting T cells and not to human B cells (unpublished work). An Mr 60,000 protein is immunoprecipitated from activated human T lymphocytes that is identical to the protein recognized by B1-49-9, a monoclonal antibody that has been found to recognize the same antigenic determinant as anti-Tac (10) . 2A3, like anti-Tac (4, 26) and B1-49-1 (unpublished work), also prevents the absorption of IL-2 by PHA-activated human T cells and inhibits the IL-2dependent proliferation of antigenor lectin-activated human T cells (unpublished observations).
2A3 was used in the current study to purify the IL-2 receptor from cells in amounts sufficient for chemical analysis. The unusually high affinity of the 2A3 monoclonal antibody, coupled with its stability to radioiodination, enabled the development of sensitive assays to detect and quantitate the presence of receptor in solution. Receptor purification could thus be monitored chemically by specific activity.
The starting material for the purification of the receptor from HuT-102 cells had a specific activity of 1.26 fmol of receptor per gg of protein and represented a total of 318 pmol of receptor extracted from 2 x 109 HuT-102 cells. This suggests that, on average, the HuT-102 cells expressed 96,000 receptor molecules per cell, a value that is very similar to published reports on the number of receptors expressed on this cell line (7) .
The high affinity of the 2A3 antibody for the receptor, which was such an advantage in the sensitive detection of receptor, was a disadvantage in the affinity purification of the receptor. The major loss of receptor occurred on the 2A3 affinity column; only 15% of the starting activity could be recovered from the column with 6 M Gdn HCl. Moreover, this protein was eluted in a relatively broad peak. The loss of activity did not seem to be a simple denaturation of the receptor by the eluting solvent, since the amount of receptor seen on silver gels and ultimately detected by protein sequencing was in close agreement with the amount of receptor measured in the soluble receptor assay.
Reversed-phase HPLC accomplished two things in the purification scheme. It achieved purification of the IL-2 receptor to a single protein of Mr 55,000 detected by silver stain on a polyacrylamide gel, and it concentrated the receptor in a clean volatile solvent that was ideal for application to protein sequencing.
The purification of the IL-2 receptor from activated human T cells presented a more difficult problem. The specific activity of the starting material was 0.27 fmol of receptor per ,ug of protein, five times lower than that of the HuT-102 extract. Furthermore, the volume of the starting material was five times greater. The same purification scheme resulted in the isolation of a protein that ran with an M, of 60,000greater in Mr by 5000 than the receptor isolated from the IL-2 Receptor: HuT-102 Cells Approximately 40 pmol of HuT-102 receptor and -60 pmol of PHA-PBL receptor were applied to the sequencer. Position 3 was assigned as cysteine due to lack of significantly high signals for other residues; sulfhydryl groups were not modified before sequencing.
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transformed HuT-102 cell line (compare Fig. 2b with Fig. 3 ). These results are in accord with radioimmunoprecipitation studies that demonstrate a consistent difference of 5000-8000 in Mr between the receptors isolated from normal and malignant cells (7, 9, 10, 14) . Preliminary reports suggest that this difference in molecular weight is because of differences in post-translational processing of the molecule (14) .
The chemical purification of the IL-2 receptor from any source has, to our knowledge, not been reported previously. The purification of receptor from both HuT-102 cells and normal activated T cells has permitted their direct chemical comparison by NH2-terminal sequencing. The results (Fig.  4 ) strongly reinforce the notion that the two molecules are probably identical in their polypeptide chains, although this statement cannot be made rigorously without the entire protein or DNA sequence for the receptor from both sources, especially since the receptor isolated from PHA-PBL was less homogeneous and the tentative sequence was less unambiguous than that determined for the receptor isolated from HuT-102 cells.
The characterization of the IL-2 receptor is of interest, not only because it elucidates a new aspect of IL-2 biology but also because it may promote an understanding of T-cell malignancy. A great deal of excitement has been generated recently in cancer biology by the observations that onc genes can be homologous to various normal proteins involved in the control of cell proliferation. The sis onc gene, for example, is homologous to platelet-derived growth factor (11, 27, 28) . The v-erbB onc gene is homologous to a portion of the epidermal growth factor receptor (13) . It is therefore of interest that the IL-2 receptor has a different molecular weight on transformed cells and that its expression has been observed in human T-cell tumors of human T-cell leukemia virus etiology (12) . We have recently used the protein sequence described here to construct synthetic oligonucleotides, which were then used to clone the cDNA encoding the IL-2 receptor from a cDNA library prepared from HuT-102 mRNA. Preliminary DNA sequencing of this clone has confirmed the sequence depicted in Fig. 4 , including position 3 as a cysteine. The cloning of the HuT-102 IL-2 receptor gene will be the subject of a separate communication.
